                                                                     
                                                                     
                                                                     
                                             
                         SEQUENCE LISTING

<110>  Roche Diagnostics GmbH
       F. Hoffmann-La Roche AG
       Roche Molecular Systems, Inc.
       
 
<120>  Methods For The Enrichment Of Mutated Nucleic Acid From A Mixture

<130>  P31873-WO-KOE

<150>  USSN 61/909,587
<151>  2013-11-27

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Wild-type sense oligonucleotide

<400>  1
cgtgcagctc atcacgcagc tcatgccctt                                        30


<210>  2
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mutant sense oligonucleotide

<400>  2
cgtgcagctc atcatgcagc tcatgccctt                                        30


<210>  3
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Affinity-labeled antisense oligonucleotide


<220>
<221>  misc_feature
<222>  (30)..(30)
<223>  Biotin

<400>  3
aagggcatga gctgcatgat gagctgcacg                                        30


<210>  4
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Wild-type antisense oligonucleotide

<400>  4
aagggcatga gctgcgtgat gagctgcacg                                        30


<210>  5
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mutant antisense oligonucleotide

<400>  5
aagggcatga gctgcatgat gagctgcacg                                        30


